Mechanisms of resistance to irreversible epidermal growth factor receptor tyrosine kinase inhibitors and therapeutic strategies in non-small cell lung cancer

Epidermal growth factor receptor (EGFR) T790M mutation is the most frequent mechanism which accounts for about 60% of acquired resistance to first-generation EGFR tyrosine kinase inhibitors (TKIs) in non-small cell lung cancer (NSCLC) patients harboring EGFR activating mutations. Irreversible EGFR-T...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jing, Wang, Jinghui, Zhang, Shucai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685774/
https://www.ncbi.nlm.nih.gov/pubmed/29163853
http://dx.doi.org/10.18632/oncotarget.21164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685774/
https://www.ncbi.nlm.nih.gov/pubmed/29163853
http://dx.doi.org/10.18632/oncotarget.21164

Ejemplares similares